| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443055 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
HPV was identified in a large proportion of invasive vaginal cancers and in almost all VAIN 2/3. HPV16 was the most common type detected. A large impact in the reduction of the burden of vaginal neoplastic lesions is expected among vaccinated cohorts.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
L. Alemany, M. Saunier, L. Tinoco, B. Quirós, I. Alvarado-Cabrero, M. Alejo, E.A. Joura, P. Maldonado, J. Klaustermeier, J. Salmerón, C. Bergeron, K.U. Petry, N. Guimerà , O. Clavero, R. Murillo, C. Clavel, V. Wain, D.T. Geraets, F.X. Bosch,